Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT TrialAdnan Nagrial, Oliver Klein, Matteo S. Carlino et al.|Clinical Cancer Research|2026Cited by 0
Data from Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT TrialAdnan Nagrial, Oliver Klein, Matteo S. Carlino et al.|Unknown|2026Cited by 0
Supplementary Table S1 from Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT TrialAdnan Nagrial, Oliver Klein, Robert Zielinski et al.|Unknown|2026Cited by 0